Sulpirid Hasco

Leaflet attached to the packaging: patient information

Sulpiryd Hasco

50 mg, tablets

Sulpiryd Hasco

100 mg, tablets

Sulpiryd Hasco

200 mg, tablets

Sulpiridum

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Sulpiryd Hasco and what is it used for
• 2. Important information before taking Sulpiryd Hasco
• 3. How to take Sulpiryd Hasco
• 4. Possible side effects
• 5. How to store Sulpiryd Hasco
• 6. Contents of the packaging and other information

1. What is Sulpiryd Hasco and what is it used for

Sulpiryd Hasco tablets are intended for the treatment of severe mental disorders. The medicine prevents the action of certain substances in the brain, leading to the alleviation of disease symptoms. The active substance of the medicine, sulpiride, has antipsychotic and antidepressant effects and belongs to the group of so-called neuroleptics, benzamide derivatives. Sulpiryd Hasco is used in the treatment of:

• acute and chronic psychoses occurring in schizophrenia, especially those with impaired activity;
• depressive disorders, if treatment with other antidepressant medicines is ineffective or impossible to apply.

2. Important information before taking Sulpiryd Hasco

When not to take Sulpiryd Hasco

• If the patient is allergic to the active substance, sulpiride, or to other benzamide derivatives or to any of the other ingredients of this medicine (listed in section 6).
• If a phaeochromocytoma (usually a benign adrenal gland tumor, a common cause of secondary hypertension) is suspected or confirmed in the patient.

1/8

• In the case of acute porphyria (a congenital or acquired disorder of heme synthesis, a substance belonging to the chemical group of porphyrins).
• If the patient has tumors associated with excessive prolactin secretion (e.g., pituitary adenoma, breast cancer).
• In the case of concomitant administration of levodopa-containing medicines.
• In breastfeeding women.
• In children and adolescents under 14 years of age.

Warnings and precautions

Before starting treatment with Sulpiryd Hasco, discuss it with your doctor or pharmacist. In some patients, sulpiride, when used in high doses, has caused motor agitation. In the phase of aggression or agitation, small doses of the medicine may exacerbate such symptoms. Caution should be exercised in case of hypomania (a state of elevated mood, characterized by increased energy, reduced need for sleep, increased physical and mental efficiency). In aggressive or agitated patients who also exhibit impulsivity, sulpiride-containing medicines can be administered together with an appropriately selected sedative by the doctor. Particular caution should be exercised when using sulpiride in patients with Parkinson's disease, for whom neuroleptic treatment is necessary. In a small number of patients, extrapyramidal symptoms (e.g., hand tremors, head, sudden muscle contractions, inability to sit or stay in one place, strange, rhythmic uncontrolled movements, most often in the face) and restlessness (akathisia) may occur, and the doctor may recommend reducing the dose of the medicine or using anti-Parkinson's disease medicines. Similarly, as with other neuroleptic medicines, the possibility of a severe adverse reaction, namely neuroleptic malignant syndrome (characterized by, among other things, increased body temperature, muscle stiffness, instability of the autonomic nervous system, impaired consciousness, increased activity of certain enzymes in the blood, such as creatine kinase - CPK), which can be life-threatening, should be taken into account. In case of such symptoms, the use of all antipsychotic medicines, including sulpiride, should be discontinued. After sudden discontinuation of antipsychotic medicines, acute symptoms may occur, including nausea, vomiting, increased sweating, and insomnia. There may also be a recurrence of the disease and the occurrence of involuntary movements (akathisia, dystonia, dyskinesia). Therefore, it is recommended to gradually discontinue the medicine. Neuroleptics can lower the seizure threshold. After using sulpiride, cases of seizures have been reported in patients who had not previously experienced them. During sulpiride treatment, caution should be exercised in patients with unstable epilepsy, and patients with a history of seizures should be closely monitored. The dosage of antiepileptic medicines should not be changed in patients who require concomitant use of sulpiride. As with other medicines excreted mainly by the kidneys, caution should be exercised when using sulpiride in patients with renal impairment. The dose of sulpiride should be reduced and adjusted gradually. Sulpiride may increase the risk of serious heart rhythm disorders - ventricular arrhythmias. Caution should be exercised when using sulpiride in patients with heart rhythm disorders and cardiovascular disorders. The use of sulpiride with other neuroleptics should be avoided. 2/8 Caution should be exercised when using this medicine, especially if the patient or their family members have a history of venous thrombosis. The use of this type of medicine is associated with the risk of venous thrombosis. Sulpiride should be used with caution in patients at risk of stroke. Elderly patients Usually, the same doses are used as in younger adults, but elderly patients may be more prone to certain adverse effects of sulpiride, such as orthostatic hypotension, excessive sedation, and extrapyramidal symptoms. Therefore, in these patients, sulpiride, like other neuroleptic medicines, should be used with caution. In elderly patients with impaired renal function, the doctor will recommend an appropriate dose reduction, depending on the patient's condition. Patients with renal and/or hepatic impairment In patients with impaired renal and/or hepatic function, the doctor will recommend an appropriate dose reduction, depending on the patient's condition.

Children and adolescents

Due to the lack of sufficient clinical data, sulpiride should not be used in children and adolescents under 14 years of age.

Sulpiryd Hasco and other medicines

Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. Sulpiryd Hasco should not be used with levodopa-containing medicines. During treatment with Sulpiryd Hasco, avoid taking any alcoholic beverages and medicines containing alcohol.

It is not recommended to use Sulpiryd Hasco with the following medicines:

• those that cause a decrease in heart rate - bradycardia, such as beta-blockers, calcium channel blockers (e.g., diltiazem, verapamil), clonidine, guanfacine, and medicines with similar effects to digitalis;
• those that cause electrolyte imbalance, particularly hypokalemia (diuretics, medicines that stimulate gastrointestinal motility, intravenously administered amphotericin B, glucocorticoids, tetracosactide); in such cases, the doctor will recommend appropriate potassium supplements;
• antiarrhythmic medicines (belonging to class Ia, such as quinidine, disopyramide, class III, such as amiodarone, sotalol);
• other medicines, such as pimozide, sultopride, haloperidol, methadone, tricyclic antidepressants derived from imipramine, halofantrine, lithium, cyzapride, bepridil, tiorydazine, intravenously administered vincamine, entamide, erythromycin, sparfloxacin.

Sulpiryd Hasco with food, drink, and alcohol

Sulpiryd Hasco should be taken at least one hour before a meal or two hours after a meal, as the presence of food reduces the absorption of the medicine. During treatment with Sulpiryd Hasco, avoid taking any alcoholic beverages and medicines containing alcohol.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before taking this medicine. Pregnancy Do not use sulpiride during pregnancy. Newborns exposed to antipsychotic medicines (including amisulpride, similar to sulpiride) during the third trimester of pregnancy are at risk of adverse reactions, including extrapyramidal symptoms and/or withdrawal symptoms. The severity of these symptoms may vary depending on the severity of the disease and the duration of labor. Observed symptoms include agitation, increased or decreased muscle tone, tremors, drowsiness, respiratory distress syndrome, or feeding disorders. Newborns should be closely monitored. Breastfeeding Do not use sulpiride in breastfeeding women. Sulpiride passes into human milk in sufficient quantities to cause pharmacological effects in the child.

Driving and operating machines

Patients, especially those who drive vehicles and operate machines, should be warned about the possibility of drowsiness associated with the use of this medicine.

Sulpiryd Hasco contains lactose

If you have previously been diagnosed with intolerance to some sugars, consult your doctor before taking this medicine. Each Sulpiryd Hasco 50 mg film-coated tablet contains 20 mg of lactose. Each Sulpiryd Hasco 100 mg film-coated tablet contains 40 mg of lactose. Each Sulpiryd Hasco 200 mg film-coated tablet contains 80 mg of lactose.

3. How to take Sulpiryd Hasco

Always take this medicine exactly as your doctor has told you. If you are not sure, consult your doctor or pharmacist.

The doctor will determine the dose of the medicine according to the patient's condition and the course of treatment.

4/8 If you feel that the effect of Sulpiryd Hasco is too strong or too weak, consult your doctor or pharmacist. Schizophrenia The usual initial dose is 400-800 mg per day, divided into two doses (morning and early evening), depending on the severity of symptoms. The maximum daily dose is 1200 mg. Only in cases of treatment-resistant disorders may the psychiatrist increase the daily dose to 1600 mg, divided into doses. Depressive disorders The usual initial dose is 50-150 mg per day. Then the dose is increased to 150-300 mg per day. Elderly patients The same doses are usually used as in younger adults. In elderly patients with impaired renal function, the dose of the medicine should be reduced. Patients with renal impairment The dose of sulpiride should be adjusted accordingly; depending on the degree of renal impairment, the dose should be reduced or the interval between doses prolonged. Sulpiryd Hasco tablets are best taken with water. Sulpiride should not be taken in the late evening hours (after 4 pm), due to the possibility of sleep disturbances. Do not take sulpiride at the same time or within 2 hours of taking antacids or sucralfate.

Using a higher than recommended dose of Sulpiryd Hasco

In case of taking a higher dose of Sulpiryd Hasco than recommended or accidental ingestion of the medicine by another person, immediately consult a doctor, pharmacist, or the nearest hospital. Take the remaining tablets and the patient information leaflet with you to show the doctor, who will decide on further action depending on the dose taken and symptoms of overdose. Symptoms of overdose include: excessive sedation, restlessness, confusion (disorientation), impaired consciousness, agitation, extrapyramidal symptoms (e.g., hand tremors, head, sudden muscle contractions, inability to sit or stay in one place, strange, rhythmic uncontrolled movements, most often in the face), decreased blood pressure. Coma may occur. As with poisoning with other orally administered medicines, activated charcoal can be administered shortly after ingestion to reduce absorption, and the doctor may perform gastric lavage. If necessary, the patient will be monitored and treated symptomatically in a hospital setting. If necessary, the doctor will recommend appropriate symptomatic treatment (e.g., administer anti-Parkinson's disease medicines).

Missing a dose of Sulpiryd Hasco

Do not take a double dose to make up for a missed dose. If you miss a dose, take it as soon as possible. If it is almost time for the next dose, do not take the missed dose.

Stopping treatment with Sulpiryd Hasco

Do not stop taking this medicine without first consulting your doctor. If you have any further doubts about taking this medicine, consult your doctor or pharmacist. 5/8 If necessary, the doctor will determine the appropriate way to stop treatment, depending on the individual patient's response to sulpiride treatment. Sulpiride administration should be discontinued immediately only in case of neuroleptic malignant syndrome (see "Warnings and precautions") or hypersensitivity (see "When not to take Sulpiryd Hasco").

4. Possible side effects

Like all medicines, Sulpiryd Hasco can cause side effects, although not everybody gets them. Blood clots in the veins, especially in the legs (symptoms include swelling, pain, redness of the legs), can travel through the bloodstream to the lungs, causing chest pain and difficulty breathing. If you experience such symptoms, seek medical attention immediately. If you experience fever without a clear cause, stop taking Sulpiryd Hasco and consult your doctor. The side effects of sulpiride are listed below by system organ class and frequency of occurrence, if available: Very common - occurs in more than 1 in 10 patients Common - occurs in less than 1 in 10 patients Uncommon - occurs in less than 1 in 100 patients Rare - occurs in less than 1 in 1000 patients Very rare - occurs in less than 1 in 10,000 patients Frequency not known - frequency cannot be estimated from available data.

The following adverse reactions have been reported in patients treated with sulpiride:

Cardiac disorders Single cases: torsade de pointes(ventricular tachycardia). Endocrine disorders Frequency not known: hyperprolactinemia (elevated prolactin levels in the blood), amenorrhea, gynecomastia (breast enlargement in men), sexual indifference, and impotence. Hepatobiliary disorders Very rare: increased liver enzyme activity. Nervous system disorders Common: sedation, drowsiness. Rare: extrapyramidal symptoms and acute dyskinesia, late dyskinesia (rhythmic involuntary movements, mainly of the tongue and/or facial muscles) observed, as with other neuroleptics, after long-term treatment. Anticholinergic anti-Parkinson's disease medicines are ineffective in such cases and may even worsen symptoms; neuroleptic malignant syndrome (see "Warnings and precautions"). Reproductive system and breast disorders Frequency not known: galactorrhea (milk secretion in men or women, unrelated to pregnancy), amenorrhea, gynecomastia. Eye disorders Rare: rotational eye movements. Vascular disorders Frequency not known: orthostatic hypotension. During treatment with antipsychotic medicines, cases of venous thrombosis, including deep vein thrombosis, have been reported. Gastrointestinal disorders Frequency not known: excessive salivation. Musculoskeletal and connective tissue disorders Rare: spastic neck contraction, trismus. Pregnancy, puerperium, and perinatal period Neonatal withdrawal syndrome (see "Pregnancy and breastfeeding"). Diagnostic tests Single cases: prolonged QT interval on the ECG. General disorders and administration site conditions Frequency not known: neuroleptic malignant syndrome, which can be life-threatening (as with all neuroleptics), weight gain. Skin and subcutaneous tissue disorders Very rare: maculopapular rash. In elderly patients with dementia, treated with antipsychotic medicines, there is a small increased risk of mortality compared to those not treated with such medicines.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49 21 301, fax: 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Sulpiryd Hasco

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month. Store in a temperature below 25°C. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the packaging and other information

What Sulpiryd Hasco contains

7/8

• The active substance of the medicine is sulpiride. One Sulpiryd Hasco 50 mg tablet contains 50 mg of sulpiride. One Sulpiryd Hasco 100 mg tablet contains 100 mg of sulpiride. One Sulpiryd Hasco 200 mg tablet contains 200 mg of sulpiride.
• The other ingredients (excipients) are: cornstarch, lactose monohydrate, povidone K30, microcrystalline cellulose, magnesium stearate.

What Sulpiryd Hasco looks like and contents of the pack

Sulpiryd Hasco 50 mg are white, round, biconvex tablets with beveled edges. One pack of Sulpiryd Hasco 50 mg contains 24, 30, 60, or 120 tablets in a cardboard box. Sulpiryd Hasco 100 mg are white, oval, biconvex tablets. One pack of Sulpiryd Hasco 100 mg contains 24, 30, 60, or 120 tablets in a cardboard box. Sulpiryd Hasco 200 mg are white, oval, biconvex tablets with a smooth surface on one side and a notch on the other side. One pack of Sulpiryd Hasco 200 mg contains 12, 30, 60, or 120 tablets in a cardboard box.

Marketing authorization holder and manufacturer

Hasco-Lek S.A., 51-131 Wrocław, ul. Żmigrodzka 242 E, Poland. Information about the medicine: tel.: 22 742 00 22, e-mail: [email protected]

Date of last revision of the leaflet:

8/8